Use of dapagliflozin in patients with advanced diabetic kidney disease

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are effective for overweight diabetic patients through the induction of glucosuria. However, SGLT2 inhibitors are not recommended for patients with advanced chronic kidney disease (CKD) because they may aggravate renal function and thus become less e...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyun Sun, Jung, Youn Joo, Lee, Dong-Young, Moon, Kyoung Hyoub, Kim, Beom, Kim, Hae Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Nephrology 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147181/
https://www.ncbi.nlm.nih.gov/pubmed/30254854
http://dx.doi.org/10.23876/j.krcp.2018.37.3.292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147181/
https://www.ncbi.nlm.nih.gov/pubmed/30254854
http://dx.doi.org/10.23876/j.krcp.2018.37.3.292

Ejemplares similares